Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled trial
ClinicalTrial.gov, NCT05081401. Registered on October 18, 2021; the record was lastupdated for study protocol version 6.0, on 06 April 2025.
Authors
- Feng Sun (ORCID: https://orcid.org/0009-0000-5287-7881)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-3474-422X)
- Pengfei Ren (ORCID: https://orcid.org/0009-0009-7912-4076)
- Yajiao Xing
- Jiqin Wu
- Yang Li
- Yan Ren
- Ting Li
- the INSPIRE TB study group
- Wenhong Zhang
Institutions
- The Sixth People's Hospital of Zhengzhou (CN)
- Huashan Hospital (CN)
- Institute of Infection and Immunity (CA)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1186/s12879-026-13017-y
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00